Interleukin 2 signaling is required for CD4(+) regulatory T cell function. - Wikidata - awgldk - TriplyDB

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

http://www.wikidata.org/entity/Q34527240

about

FOXP3 ensembles in T-cell regulation CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.Adoptive immunotherapy for cancer: building on success Interleukin-2 receptor signaling: at the interface between tolerance and immunity Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction The quantal theory of how the immune system discriminates between "self and non-self"Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer Translational utility of experimental autoimmune encephalomyelitis: recent developments PKC-Theta in Regulatory and Effector T-cell Functions Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets Ubiquitin-dependent regulation of Foxp3 and Treg function The role of autoimmunity in obliterative bronchiolitis after lung transplantation Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets Tregs control the development of symptomatic West Nile virus infection in humans and mice New Insights into Regulatory T Cells: Exosome- and Non-Coding RNA-Mediated Regulation of Homeostasis and Resident Treg Cells The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury Human β-defensin 3 induces STAT1 phosphorylation, tyrosine phosphatase activity, and cytokine synthesis in T cells.Combining cytotoxic and immune-mediated gene therapy to treat brain tumors Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells New insights into the regulation of T cells by gamma(c) family cytokines CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.TGF-beta and regulatory T cell in immunity and autoimmunity Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response.Oral tolerance in the absence of naturally occurring Tregs Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulation.Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2 Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

P2860

Q24299602-E996EC46-9B08-4FA0-976A-B2E14D2DB00C Q24540429-E4FDB4D1-2342-4A4B-8148-1E11B8B6FF03 Q24546258-836AC4B0-19DF-45D0-899B-C9A1F32E1640 Q24599806-58841D4B-BA29-4E3D-B7F5-62ABFAD3164D Q24650734-C13B8275-EA3E-4983-A636-5D8C6FFBE271 Q24803143-F6B521D4-3ADB-4246-AE6B-FE91FD867F41 Q26747008-F8162B7E-683F-42CE-95F2-24FCDD6C4E13 Q26775820-B7925F65-8B36-4256-82B3-0B87A84A8823 Q26777188-8E4DB4FE-AA9A-4A02-BD40-F3E01426D220 Q26784460-ABC3E5E1-C8F3-4D60-8836-D17E996A6DF7 Q26830569-CED2653A-D8A0-4EB5-A419-0BB0B22D5FFB Q26863525-B6307391-CA5E-45D0-B65F-8A3CAC0884DB Q27008934-914DF546-ABEC-4BCF-BB04-0F64234A3BEF Q27026592-BF9FAF3C-4755-4726-A91C-6257D25A7B7C Q27490259-D07D84E8-3F86-4D38-89CD-53B15E1F2068 Q28072363-11344FD8-BCC1-4312-9F59-77644C73C106 Q28076264-4871D057-7449-4516-AFA5-F87DE4EDC401 Q28732675-3E75DE5C-C7FF-4B02-ADC6-E6C45D0A88BE Q30435312-CB81EFFC-1101-4F8E-A4C9-3170B3AD9F53 Q30543181-83A52E37-34BE-4A0B-89B7-6EEB684BE845 Q31013320-DDD26131-F910-43D1-A1D4-BB601B55A487 Q33236315-F0C871F4-9EB6-4C03-A72E-380EDD15F095 Q33413095-AD931F4C-EAFC-4B3D-8CC5-9D1408B0659C Q33490627-FE4921E5-4D14-4B19-BC34-779F7AC207F1 Q33506644-BB9F9A70-3CAD-421A-960E-D4FCB06710BC Q33623326-FAB20A3A-22EB-40E5-A847-286D5D724B10 Q33623556-BED1299C-36D6-44D5-A55A-EAA85607C796 Q33687100-683704C3-2C50-4FCC-A640-FDADD075479A Q33718865-C7E806D5-2A40-4704-A486-BDD84DA992A8 Q33722462-F38AF09A-E9C1-4DFB-983B-9079DD0BD00D Q33754742-9CC161F2-B579-40C6-B975-138258B3A2D9 Q33840440-C21BF179-E96B-4EF0-B606-8323392C9705 Q33849282-0E1C46B0-828A-4030-8275-1A0B67F7281D Q33917765-599B2B67-F59A-409C-9C5F-8A236998A0C4 Q33918375-B65C33B5-2622-4775-B4F9-2036F496E69D Q33932451-9F22EC4C-25D7-4156-9F31-3A46B9DAE7C6 Q33935142-9AC5B5AD-87E0-4437-B9EA-CCBCE431D0C1 Q34063120-ADA2209F-2476-41D5-811A-FE85B8EB2BCF Q34065797-4AA71895-75B8-4A96-8EA2-5DDD7BB04E28 Q34069579-4D5B8EB3-F3D2-4925-9167-FE634F08B4B9

P2860

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

http://www.wikidata.org/entity/Q34527240

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Interleukin 2 signaling is required for CD4

@nl

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@ast

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@en

type

label

Interleukin 2 signaling is required for CD4

@nl

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@ast

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@en

prefLabel

Interleukin 2 signaling is required for CD4

@nl

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@ast

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@en

P1433

Q34527240-84B0A1E9-2C8C-4AF8-8328-6B07422F8CD2

P1476

Q34527240-A6F00BD2-C9B9-4F60-894B-59F5B007A73F

P2093

Q34527240-011433B6-38BE-4AC0-8C65-DC093A99286E

Q34527240-51FCCE9F-811E-4FA6-9D20-2703EE9EF11B

Q34527240-9C44A40C-75BE-4840-8C39-CF11FE21D588

Q34527240-B70ADDED-22B1-47DC-92A6-2A078A6C42EF

P2860

Q34527240-20E47BC1-5C4E-4D6F-83DF-971C0317EB88

Q34527240-2767A6F8-0E15-4C25-9D79-00A4189709AB

Q34527240-2A051001-4DA7-4CC7-ADB5-8B6DF16CB6E9

Q34527240-3919F276-C7A3-4A72-B232-1F89A5B879F7

Q34527240-42D5FEDC-9034-47C6-BC47-A068B367B231

Q34527240-433B6973-FB39-4E86-BAF6-DE9B15EB3A98

Q34527240-43AE706D-5B92-4B82-8527-098E8B7F524E

Q34527240-441755BF-955A-4CF6-ACD6-9D88A2E3F7FB

Q34527240-46EB48DC-D0E4-4173-80FC-B20F2F1781E4

Q34527240-4E50E963-2EE9-43F5-AFFC-37DE8CF9A39C

P304

Q34527240-F462B3B3-1018-4304-A1D9-4DCABF578D15

P31

Q34527240-4EB5FB93-5C5A-4335-98B6-2354B62E87E6

P356

Q34527240-8CB5F8E0-F378-4118-9959-AF33AB676C53

P407

Q34527240-E9497A20-4452-403D-826F-E954C5FB1B13

P433

Q34527240-3E5C5C1A-5400-4FF2-9883-1B967296A9D3

P478

Q34527240-59A4F419-F186-4227-9D84-4CB6A32E29E4

P577

Q34527240-A931562F-9648-4749-9242-827C8B59A1C8

P5875

Q34527240-F578CBEE-C69F-4875-B337-07F8B104F0EB

P698

Q34527240-EF5A2D5C-75EC-42B6-BDF0-BD39D923E045

P921

Q34527240-7e9fdf33-0bfa-4403-91fb-ec3695142079

P932

Q34527240-DA0601FE-8DD8-4370-AF52-A20812CDB0AA

P356

P1433

Journal of Experimental Medicine

P1476

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

@en

P2093

Gláucia C Furtado

http://www.w3.org/2001/XMLSchema#string

Juan J Lafaille

http://www.w3.org/2001/XMLSchema#string

Maria A Curotto de Lafaille

http://www.w3.org/2001/XMLSchema#string

Nino Kutchukhidze

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 2 regulates its own receptors

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

Regulatory T cells in autoimmmunity*.

Regulatory T cells: key controllers of immunologic self-tolerance.

P304

851-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20020190

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11155900

http://www.w3.org/2001/XMLSchema#string

P698

12235217

http://www.w3.org/2001/XMLSchema#string

P921

P932

2194060

http://www.w3.org/2001/XMLSchema#string